| |
| |
SPOT ON
|
 |
Simvastatin (e.g. ZOCOR) for every diabetic? |
| |
| |
THERAPIES FROM A CRITICAL VIEWPOINT
|
| |
Hip operation: prophylaxis against venous thromboembolism in out-patients
Fly maggots for wound management?
|
| |
| |
RECOMMENDED TREATMENTS
|
| |
Acetylsalicylic acid plus clopidogrel instead of ticlopidin after elective stent implantation |
| |
| |
NEW ON THE MARKET
|
| |
HIV: fusion inhibitor enfuvirtide (FUZEON) |
| |
| |
BEWARE! MISINFORMATION
|
| |
Will ZOCOR MSD win the race?
Tacrolimus ointment (PROTOPIC): treatment pauses, relapses
|
| |
| |
a-t READERS' QUESTIONS AND COMMENTS
|
| |
Orthomolecular medicine: what is it good for?
Suicidality associated with paroxetine
Problems with PEGINTRON Injektor
|
| |
| |
IN BRIEF
|
| |
Finasteride (PROSCAR) for prevention of prostate cancer?
Prednisone (e.g. DECORTIN) after exacerbation of
chronic obstructive pulmonary disease
Finally: restrictions on beta carotine
New: gabapentin and lovastatin as generics
Estrogen replacement therapy: significantly fewer prescriptions
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
TRAMABETA LONG: disadvantage of a specific formulation |
| |
| |
SIDE EFFECTS
|
| |
Breast cancer during hormone replacement therapy:
a special risk
|
| |